<DOC>
	<DOCNO>NCT00496067</DOCNO>
	<brief_summary>The primary objective study evaluate safety effectiveness Doppler guide Uterine Artery Occlusion ( D-UAO ) treatment reduction fibroid-associated symptom .</brief_summary>
	<brief_title>Uterine Artery Occlusion Fibroid Related Bleeding</brief_title>
	<detailed_description>DUAO intend bilateral occlusion uterine artery</detailed_description>
	<mesh_term>Leiomyoma</mesh_term>
	<mesh_term>Myofibroma</mesh_term>
	<mesh_term>Menorrhagia</mesh_term>
	<criteria>25 50 year age Subject negative urine blood pregnancy test prior procedure . At time enrollment study , subject intent childbearing intend use appropriate contraception throughout first 12 month study period ( unless sterilize ) Normal pap smear within 36 month study procedure ( recent ) Cervix suitable tenaculum placement determine pelvic exam ( adequate length cervix , absence cervical fibroid/lower fibroid prevent clamp placement ) At least one intramural subserosal submucosal uterine fibroid minimum diameter great equal 3 cm , fibroid diameter less equal 8cm prevail pathology ( e.g. , opposed adenomyosis ) fibroid determine ultrasound Symptomatic subject present least one follow fibroid symptom : pelvic pressure , menorrhagia , metrorrhagia , pelvic pain , increase abdominal girth dyspareunia due fibroid . Subject evidence bilateral ureteric flow Subject agree participate study , include completion studyrelated procedure evaluation , document agreement sign Ethics Committeeapproved inform consent . Pregnancy confirm positive urine blood pregnancy test Menopausal define elevated folliclestimulating hormone ( FSH ) decrease oestradiol hormone level determine hospital local laboratory reference range criterion Presence pedunculated submucosal pedunculated subserosal fibroid ( ) determine MRI , ultrasound hysteroscopy Presence intrauterine device ( IUD ) Any hydronephrosis determine renal ultrasound prior procedure Clinical history thromboembolic disease know thrombophilia Blood Urine Nitrogen ( BUN ) great 7.2mmol/L* and/or serum creatinine great 106Î¼mol/L* unresolved change diet hydration History current evidence gynecologic malignancy ( confirm hysteroscopy endometrial biopsy ) , atypical endometrial hyperplasia , chronic pelvic inflammatory disease Pelvic mass outside uterus uterine fibroid Any current acute chronic systemic infection localize pelvic infection , include urinary tract infection Use GonadotropinReleasing Hormone ( GnRH ) agonist , danozol mifepristone within 6months prior start study procedure Using anticoagulation therapy ( except counter treatment ( e.g . aspirin ) ) , underlie bleed disorder Unsuitable MRI examination ( e.g . severe claustrophobia , nonMRIcompatible implant metalloid device ) Prior endometrial ablation , uterine artery embolization , uterine artery ligation Poor procedural candidate due medical condition determine investigator ( e.g . anesthesia class , renal insufficiency , heart disease ) ;</criteria>
	<gender>Female</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>Fibroids</keyword>
	<keyword>Menorrhagia</keyword>
	<keyword>Menorrhagia associate uterine fibroid</keyword>
</DOC>